Clinical Trial Update: Inflammatory Response to Salt in Essential Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the inflammatory response to salt in individuals with essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Snippet

Sponsor: Carmine Zoccali | Conditions: Essential Hypertension. | Phase 3 | Status: COMPLETED